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Outcomes of Excimer Laser Atherectomy for the Treat-
ment of Infrainguinal Occlusive Disease in Patients
With Critical Limb Ischemia
Edouard Aboian, Brian W. Nolan, Philip P. Goodney,
David H. Stone, Daniel B. Walsh, Richard Powell. Dart-
mouth Hitchcock Medical Center, Lebanon, NH
Objectives: To evaluate outcomes of patients undergoing
Excimer Laser atherectomy (ELA) for the treatment of infrain-
guinal occlusive disease in patients with critical limb ischemia.
Methods: A retrospective review of all patients who
underwent infrainguinal ELA for critical limb ischemia at
Dartmouth-Hitchcock Medical Center from November
2005 to December of 2008 was performed. The primary
outcome measure was limb salvage. Secondary outcomes
included amputation free survival and freedom from rein-
tervention. Data were analyzed using life table analysis.
Results: Fifty-two procedures were performed. The av-
erage patient age was 76 years, 73% had tissue loss. Fifty five
percent had undergone prior interventions. The superficial
femoral artery was treated in 47% of cases, the popliteal artery
in 25% and the tibial arteries in 28%. Sixty-five percent of
treated lesions were occlusions; with 41 percent of lesions
being TASC C and 43 percent TASC D lesions. Median
follow-up was 14-months (range 2-days to 43-months).
Overall technical success was achieved in 92%. Transluminal
angioplasty or stent deployment was required for residual
stenosis or dissection following ELA in 85% percent of cases.
Technical complications occurred in 10 patients (19%). Distal
embolization occurred in 2 cases, arterial perforation in 3 cases
and dissection in 5 cases. Ipsilateral limb salvage was 75% at
one year and amputation free survival rate was 65%. Freedom
from reintervention was 54% at one year, and 10 (20%) pa-
tients went on to require lower extremity bypass.
Conclusions:ELAcanbeused safelywith ahighdegreeof
success for treatment of multilevel infrainguinal arterial disease,
though it is not sufficient as stand alone therapy. While reason-
able limb salvage rates can be achieved, long-term patency is
difficult to maintain and warrants careful follow-up.
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The 6L Irish Pivotal Trial Comparing Three-Year Out-
comes of Cool Excimer Laser Assisted Angioplasty
(CELA) and Tibial Balloon Angioplasty (TBA) in Man-
agement of Infragenicular Tibial Arterial Occlusion in
Critical Lower Limb Ischaemia (CLI) TASC D E
Sherif Sultan1, Wael Tawfick1, NiamhHynes2. 1Vascular &
Endovascular Surgery, Western Vascular Institute, Galway,
Ireland; 2Galway Clinic, Galway, IrelandObjectives: Despite advances in Endovascular revascu-
larisation (EvR), there is still concern over its capability to
treat complex Tibial lesions. We aim to compare outcomes
of CELA vs TBA in CLI, TASC-II DE.
Methods: From 2005-2009, 1506 patients were re-
ferred with PVD, 572 had CLI. 80 underwent 89 EvRs for
tibial TASC-II DE; 47 using TBA and 42 using CELA.
Results: Technical Success was 81% for CELA vs 74%
for TBA. Improvement to Rutherford Category 3 oc-
curred in 90% of CELA vs 70% of TBA with hemodynamic
Success in 95% of CELA vs 70% of TBA. 3-year sustained
clinical improvement was significantly enhanced with
CELA at 81% compared to TBA at 63.8%, (p  0.013).
3-year amputation Free Survival rates were also significantly
improved at 95.2% for CELA vs 89.4% for TBA. (p 
0.0165) 3-year freedom from binary restenosis was im-
proved with CELA at 83.3% compared with TBA at 55.3%
(p  0.0845).3-year freedom from TLR was also aug-
mented with CELA at 95.2% in comparison to TBA at
63.8%, albeit not significantly (p 0.872). However 3-year
freedom from TER was significantly superior with CELA
(92.9% vs 78.7%p  0.026). 3-year freedom from MACE
was improved with CELA (85.7% vs 57.4%, p 0.455), but
this did not reach statistical significance. However, CELA
patients had a significant improvement in Q-TWiST at 3
years of 10.5 months. Incremental cost effectiveness ratio
of €2, 073.19 per QALY was gained in favor of CELA.
Conclusions: Prospective Clinical Prelude showed os-
tial lesions with poor distal run off have a reduced prospect
of distal embolisation. CELA ameliorated PTA, if used
primarily in instances where the wire can cross the lesion
but not the balloon. Initially compromised endeavors’ at
Crural PTA can be treated successfully with redo PTA
without spoiling subsequent attempts at bypass grafting.
Both CELA and TBA can be successful in complex tibial
vessel lesions. However, CELA has superior freedom from
binary restenosis, freedom from TLR and 3 years survival
free from MACE, with improved Q-TWiST and cost per
QALY.
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Vascular Surgery in the Elderly Patient—Should Age
Affect Treatment Strategy?
Gavin C. O’Brien, Zenia Martin, Mary Paula Colgan, Sean
O’Neill, Dermot Moore, Prakash Madhavan. Vascular Sur-
gery, St James Hospital, Dublin, Ireland
Objectives: The incidence of arterial disease increases
with age. Increasing life expectancy in the western world
will intensify demands on vascular surgeons with regard to
increasing caseload, expanding patient selection criteria,
and more complex and minimally-invasive treatment op-
tions. We analysed our arterial cases over the past 31 years
